Search

everythinglearnresearchcommunity

for

Search:↓

Methotrexate dose has little effect on its toxicity when used with adalimumab for early rheumatoid arthritis.

Adalimumab improved folliculitis decalvans in most patients.

Infliximab can trigger lupus-like symptoms in Crohn's disease patients.

Some systemic treatments work for nail psoriasis but can have serious side effects.

Adalimumab was safe but mostly ineffective for severe alopecia areata.

Ro 10-9359 is an effective treatment for severe psoriasis but can cause side effects.

A woman had severe reactions to methotrexate, including skin issues and organ problems, but improved after 38 days in the hospital.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

Lenalidomide effectively and safely treats skin symptoms in pediatric lupus, reducing the need for prednisone.

A patient with multiple sclerosis developed skin reactions after Daclizumab treatment, requiring more data on the drug's effects.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

Alefacept does not effectively treat severe alopecia areata.

The combination of vitamin D analogues with potent steroids is a favorable treatment for alopecia areata with fewer side effects.

Ustekinumab effectively treated psoriasis and ulcerative colitis in a teen after infliximab caused complications.

Brodalumab is more effective than ustekinumab for treating psoriasis.

Azathioprine can cause severe hair loss and low white blood cell count in lupus patients.

Mini pulse corticosteroid therapy with oral dexamethasone is effective and has fewer side effects for treating extensive alopecia areata.

Most children with skin inflammation taking methotrexate had lab abnormalities, but liver issues often improved without changing the medication dose.

Many patients on methotrexate experience significant side effects but still continue the medication.

Belimumab effectively controls SLE disease activity and reduces steroid use.

SM04755 may be an effective topical treatment for psoriasis.

Mogamulizumab treatment in Sézary syndrome may cause skin issues and hair loss but can lead to a complete response.

The combination therapy may be more effective for mild alopecia areata, especially in patients with allergies.

The patient's symptoms improved with treatment but recurred when the steroid dose was reduced, requiring ongoing therapy.

Apremilast improved symptoms in patients with severe skin conditions.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

Methotrexate for rheumatoid arthritis often causes side effects like diarrhea, fatigue, and hair loss, especially at higher doses.

Dexamethasone oral mini-pulse therapy effectively treats severe alopecia areata when JAK inhibitors can't be used.

Cal/BD aerosol foam effectively treats scalp psoriasis, improving symptoms and patient satisfaction.